Israel is a global leader in cannabis research. The US, on the other hand, is not. The cannabis grown for research in the US is basically dirt weed, leaving little for legal scientific research to learn from. With the recent backlash on cannabis from the federal government it’s not too shocking that President Trump recently said no to importing Israeli research cannabis.
Israel Grows Quality, High-Grade Research Cannabis…Approves Exportation in 2017
In August 2017, the Israeli Finance and Health Ministries approved the export of medical cannabis. The decision was based on the findings that Israel has several advantages in the maturing marijuana market in regard to research and development, advanced regulation, and clinical experience.
“The export of medical cannabis is an industry with significant economic potential for the State of Israel and will strengthen Israeli agriculture in general and agriculture in the Arava region in particular,” said Finance Minister, Moshe Kahlon about the decision. “It will serve as an opportunity for the country to exploit its relative advantage in developing medical products from medical cannabis.”
According the Jeruselam Post, the Finances and Health Ministries recommended that exports be approved only to countries which permit the use of medical cannabis and explicitly allow import from Israel. These exports would also be approved only for farmers who receive a Health Ministry license to grow it and export the cannabis.
Trump Rejects Importation of Israeli-Grown Research Cannabis
Last Sunday, President Trump had a phone conversation with current Israeli Prime Minister Benjamin Netanyahu regarding the import of Israeli cannabis for research purposes.
Importing cannabis from Israel is something strongly supported by proponents for medical marijuana. It would allow for research on quality marijuana, rather than what is currently being used in studies conducted by the US government.
In his phone conversation with Netanyahu however, Trump quickly put an end to the idea of the US importing Israeli weed. We can’t say we’re surprised.
Trump’s decision led to Netanyahu temporarily banning cannabis exports from Israel. In the meantime, separate reviews by the Health Ministry and National Economics Council will be made before any cannabis exportation in Israel resumes.
US Research Cannabis is Shwag
In the US, the cannabis grown for research is done at one facility at the University of Mississippi. It’s funded by the National Institute on Drug Abuse (NIDA), and contains THC levels far below what’s typically present in medical-grade cannabis. Photos that have been taken of government research weed reveal that what the feds are studying is basically dirt weed.
What’s more, and probably most important, is that the cannabis grown by the NIDA has not been approved as medicine by the FDA. Basically, this boils down to the fact that as long as the shwag the NIDA is passing off as medical marijuana is used in clinical trials, it will never be approved as medicine.
Trump’s decision saying no to importing Israeli cannabis isn’t surprising, it does however leave researchers in the US up in arms. If the medicine they’re given to study isn’t even medicine, they don’t have much opportunity to present positive results from clinical trials.